2-bromo-1,4-naphthoquinone has been researched along with atovaquone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bibal, B; Bouammali, B; Cherkaoui, O; Fillion, H; Nebois, P; Pautet, F; Pétavy, AF; Sarciron, ME; Walchshofer, N | 1 |
| Chekaiban, J; Coster, MJ; Cross, M; Dallaston, MA; Davis, RA; Hofmann, A; Rajan, S; Wibowo, M | 1 |
2 other study(ies) available for 2-bromo-1,4-naphthoquinone and atovaquone
| Article | Year |
|---|---|
Quinonic derivatives active against a virulent strain of Toxoplasma gondii. Synthesis of 2-methylfuro[2,3-g]- and [3,2-g]isoquinolinetriones.
Topics: Animals; Antiprotozoal Agents; Cell Line; Furans; Humans; Monocytes; Quinolines; Toxoplasma | 2000 |
Dichloro-naphthoquinone as a non-classical inhibitor of the mycobacterial carbonic anhydrase Rv3588c.
Topics: | 2017 |